BENLYSTA
GlaxoSmithKline Intellectual Property Limited
Published for Opposition: 2016-07-12
Trademark Application Details
FOURTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86538266 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Angela L. Wilson |
| Attorney Docket Number | TMR5105976/B |
| Law Office Assigned | L40 |
| Employee Name | BRADLEY, EVELYN W |
Timeline
| 2015-02-18 | Application Filed |
| 2016-07-12 | Published for Opposition |
| 2016-09-06 | Location: INTENT TO USE SECTION |
| 2018-07-26 | Status: Live/Pending |
| 2019-01-02 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  GlaxoSmithKline Intellectual Property Limited |
| Entity Statement | private company limited by shares (prc) |
| Address | 980 Great West Road Brentford, Middles TW89GS GB2 |
| Legal Entity Type | |
| Legal Entity State | GB2 |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, blood disorders, bone diseases and injuries, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation; pharmaceutical preparations for conditioning treatment prior to bone marrow and stem cell transplantation |
Related Filings
| Mark | Serial Number | Relationship Number |
|---|---|---|
| BENLYSTA | 77979299 | 3797552 |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-02-21 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-03-04 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-03-10 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2015-03-11 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2015-03-11 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2015-03-11 | 6 GNS3 O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-06-09 | 7 TCCA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2015-10-06 | 8 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2015-10-07 | 9 RCCK S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-10-30 | 10 CNSA P: |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2015-10-30 | 11 ZZZX Z:Deletion |
| FINAL REFUSAL WRITTEN | 2015-11-21 | 12 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2015-11-21 | 13 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2015-11-21 | 14 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2016-05-09 | 15 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-05-09 | 16 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-05-10 | 17 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-05-31 | 18 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-06-06 | 19 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-06-22 | 20 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-07-12 | 21 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-07-12 | 22 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-09-06 | 23 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-03-03 | 24 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2017-03-03 | 25 EXT1 S: |
| EXTENSION 1 GRANTED | 2017-03-03 | 26 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-03-07 | 27 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-08-31 | 28 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2017-08-31 | 29 EXT2 S: |
| EXTENSION 2 GRANTED | 2017-08-31 | 30 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-09-02 | 31 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-02-13 | 32 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2018-02-13 | 33 EXT3 S: |
| EXTENSION 3 GRANTED | 2018-02-13 | 34 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-02-15 | 35 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-07-26 | 36 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2018-07-26 | 37 EXT4 S: |
| EXTENSION 4 GRANTED | 2018-07-26 | 38 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-07-28 | 39 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-02-27 | 40 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-03-04 | 41 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2019-02-27 | 42 EXT5 S: |
| EXTENSION 5 GRANTED | 2019-03-04 | 43 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-03-05 | 44 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-10-07 | 45 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-10-07 | 46 MAB6 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 